B-intervention	0	8	Exercise
O	9	16	effects
O	17	19	on
B-condition	20	23	hip
I-condition	24	28	bone
I-condition	29	36	mineral
I-condition	37	44	density
O	45	47	in
O	48	53	older
O	53	54	,
O	55	59	post
O	59	60	-
O	60	70	menopausal
O	71	77	breast
O	78	84	cancer
O	85	94	survivors
O	95	98	are
O	99	102	age
O	103	112	dependent
O	112	113	.

O	114	116	We
O	117	126	evaluated
O	127	134	whether
O	135	138	age
O	139	148	moderated
O	149	152	the
O	153	159	effect
O	160	162	of
O	163	169	impact
O	170	171	+
O	172	182	resistance
O	183	191	exercise
O	192	194	on
O	195	198	hip
O	199	202	BMD
O	203	205	in
O	206	211	older
O	212	216	post
O	216	217	-
O	217	227	menopausal
O	228	234	breast
O	235	241	cancer
O	242	251	survivors
O	252	253	(
O	253	256	BCS
O	256	257	)
O	257	258	.

O	259	267	Exercise
O	268	271	was
O	272	276	more
O	277	287	beneficial
O	288	293	among
O	294	301	younger
O	302	306	than
O	307	312	older
O	313	318	women
O	319	325	within
O	326	329	our
O	330	336	sample
O	336	337	,
O	338	348	suggesting
O	349	353	that
O	354	358	much
O	359	364	older
O	365	368	BCS
O	369	372	may
O	373	380	require
O	381	390	different
O	391	399	training
O	400	408	programs
O	409	411	to
O	412	419	improve
O	420	423	hip
O	424	430	health
O	430	431	.

O	432	442	Previously
O	442	443	,
O	444	446	we
O	447	455	reported
O	456	460	that
O	461	462	a
O	463	470	program
O	471	473	of
O	474	484	resistance
O	485	486	+
O	487	493	impact
O	494	502	training
O	503	510	stopped
O	511	515	bone
O	516	520	loss
O	521	523	at
O	524	527	the
O	528	533	spine
O	534	536	in
O	537	542	older
O	542	543	,
O	544	548	post
O	548	549	-
O	549	559	menopausal
O	560	563	BCS
O	564	567	but
O	568	571	had
O	572	574	no
O	575	581	effect
O	582	584	on
O	585	589	bone
O	590	597	mineral
O	598	605	density
O	606	607	(
O	607	610	BMD
O	610	611	)
O	612	614	at
O	615	618	the
O	619	622	hip
O	622	623	.

O	624	629	Aging
O	630	633	may
O	634	639	blunt
O	640	643	the
O	644	658	responsiveness
O	659	661	of
O	662	665	the
O	666	669	hip
O	670	672	to
O	673	683	mechanical
O	684	691	loading
O	691	692	,
O	693	695	so
O	696	698	we
O	699	708	conducted
O	709	710	a
O	711	720	secondary
O	721	725	data
O	726	734	analysis
O	735	737	to
O	738	746	evaluate
O	747	754	whether
O	755	758	age
O	759	768	moderated
O	769	772	the
O	773	779	effect
O	780	782	of
O	783	791	exercise
O	792	794	on
O	795	798	hip
O	799	802	BMD
O	802	803	.

O	804	806	We
O	807	815	analyzed
O	816	820	data
O	821	825	from
O	826	829	our
O	830	840	randomized
O	840	841	,
O	842	852	controlled
O	853	858	trial
O	859	861	in
O	862	867	older
O	868	869	(
B-age	869	870	â‰¥
I-age	871	873	50
I-age	874	879	years
O	880	882	of
O	883	886	age
O	887	889	at
O	890	899	diagnosis
O	899	900	)
O	900	901	,
B-eligibility	902	906	post
I-eligibility	906	907	-
I-eligibility	907	917	menopausal
I-eligibility	917	918	,
I-eligibility	919	923	post
I-eligibility	923	924	-
I-eligibility	924	932	adjuvant
I-eligibility	933	942	treatment
I-eligibility	943	946	BCS
O	947	948	(
O	948	949	n
O	950	951	=
B-total-participants	952	955	106
O	955	956	)
O	957	966	comparing
O	967	972	women
O	973	981	assigned
O	982	984	to
O	985	991	impact
O	992	993	+
O	994	1004	resistance
O	1005	1013	exercise
O	1014	1015	(
O	1015	1020	POWIR
O	1020	1021	)
O	1022	1024	or
O	1025	1027	to
O	1028	1029	a
B-control	1030	1037	control
I-control	1038	1045	program
O	1046	1048	of
O	1049	1052	low
O	1052	1053	-
O	1053	1062	intensity
O	1063	1073	stretching
O	1074	1075	(
O	1075	1079	FLEX
O	1079	1080	)
O	1080	1081	.

O	1082	1084	We
O	1085	1093	examined
O	1094	1100	effect
O	1101	1113	modification
O	1114	1116	by
O	1117	1120	age
O	1121	1123	on
O	1124	1127	BMD
O	1128	1130	at
O	1131	1136	three
O	1137	1140	hip
O	1141	1146	sites
O	1147	1148	(
O	1148	1155	greater
O	1156	1166	trochanter
O	1166	1167	,
O	1168	1175	femoral
O	1176	1180	neck
O	1180	1181	,
O	1182	1185	and
O	1186	1191	total
O	1192	1195	hip
O	1195	1196	)
O	1197	1202	using
O	1203	1215	hierarchical
O	1216	1222	linear
O	1223	1231	modeling
O	1232	1241	adjusting
O	1242	1245	for
O	1246	1250	time
O	1251	1256	since
O	1257	1266	diagnosis
O	1267	1270	and
O	1271	1274	use
O	1275	1277	of
O	1278	1286	adjuvant
O	1287	1294	hormone
O	1295	1302	therapy
O	1302	1303	.

O	1304	1307	Age
O	1308	1317	moderated
O	1318	1321	the
O	1322	1328	effect
O	1329	1331	of
O	1332	1340	exercise
O	1341	1343	on
B-outcome	1344	1349	total
I-outcome	1350	1353	hip
I-outcome	1354	1357	BMD
O	1358	1362	such
O	1363	1367	that
O	1368	1375	younger
O	1376	1381	women
O	1382	1384	in
O	1385	1390	POWIR
O	1391	1395	were
O	1396	1400	more
O	1401	1407	likely
O	1408	1410	to
O	1411	1414	see
O	1415	1416	a
O	1417	1425	positive
O	1426	1429	net
O	1430	1437	benefit
O	1438	1442	than
O	1443	1447	FLEX
O	1448	1456	compared
O	1457	1459	to
O	1460	1465	older
O	1466	1471	women
O	1472	1477	where
O	1478	1483	there
O	1484	1487	was
O	1488	1494	little
O	1495	1505	difference
O	1506	1513	between
O	1514	1520	groups
O	1521	1522	(
O	1522	1523	p
O	1524	1525	=
O	1526	1527	0
O	1527	1528	.
O	1528	1530	02
O	1530	1531	)
O	1531	1532	.

O	1533	1536	The
B-outcome	1537	1545	skeletal
I-outcome	1546	1554	response
I-outcome	1555	1557	to
I-outcome	1558	1565	loading
I-outcome	1566	1568	at
I-outcome	1569	1572	the
I-outcome	1573	1576	hip
O	1577	1583	within
O	1584	1588	post
O	1588	1589	-
O	1589	1599	menopausal
O	1600	1603	BCS
O	1604	1614	diminishes
O	1615	1619	with
O	1620	1623	age
O	1623	1624	.

O	1625	1632	Whether
O	1633	1637	more
O	1638	1646	vigorous
O	1647	1655	exercise
O	1656	1664	programs
O	1665	1668	and
O	1668	1669	/
O	1669	1671	or
O	1672	1678	longer
O	1679	1687	training
O	1688	1695	periods
O	1696	1699	are
O	1700	1708	required
O	1709	1711	to
O	1712	1721	favorably
O	1722	1728	change
O	1729	1732	hip
O	1733	1739	health
O	1740	1742	in
O	1743	1748	older
O	1749	1752	BCS
O	1753	1757	will
O	1758	1765	require
O	1766	1772	future
O	1773	1778	study
O	1779	1782	and
O	1783	1790	careful
O	1791	1798	thought
O	1799	1804	about
O	1805	1808	the
O	1809	1814	risks
O	1815	1818	and
O	1819	1827	benefits
O	1828	1830	of
O	1831	1838	tougher
O	1839	1847	training
O	1848	1856	programs
O	1856	1857	.
